Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2. (2022)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41564-022-01163-3
PubMed Identifier: 35836002
Publication URI: http://europepmc.org/abstract/MED/35836002
Type: Journal Article/Review
Volume: 7
Parent Publication: Nature microbiology
Issue: 8
ISSN: 2058-5276